NEUP · Neuphoria Therapeutics Inc.
Market Cap
$20.32M
Shares
5.40M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-07-24 | 2026-07-20 | |
| 8-K | 2026-05-26 | 2026-05-21 | |
| 10-Q | 2026-05-15 | 2026-03-31 | |
| 10-Q | 2026-02-17 | 2025-12-31 | |
| 8-K | 2026-01-08 | 2025-12-31 | |
| 8-K | 2025-12-18 | — | |
| 8-K | 2025-12-17 | 2025-12-12 | |
| 10-Q | 2025-11-14 | 2025-09-30 | |
| DEF 14A | 2025-10-30 | 2025-12-09 | |
| 8-K | 2025-10-27 | — | |
| 8-K | 2025-10-20 | — | |
| 10-K | 2025-09-29 | 2025-06-30 | |
| 8-K | 2025-09-16 | 2025-09-10 | |
| 8-K | 2025-07-18 | — | |
| 10-Q | 2025-05-20 | 2025-03-31 | |
| 8-K | 2025-05-20 | — | |
| 10-Q | 2025-02-14 | 2024-12-31 | |
| 8-K | 2025-01-14 | 2025-01-10 | |
| 8-K | 2024-12-23 | — | |
| 8-K | 2024-12-16 | — | |
| 8-K | 2024-12-12 | 2024-12-11 | |
| 8-K | 2024-11-21 | 2024-11-18 | |
| 10-Q | 2024-11-14 | 2024-09-30 | |
| DEF 14A | 2024-11-12 | 2024-12-11 | |
| 8-K | 2024-11-08 | — | |
| 8-K | 2024-10-10 | 2024-10-09 | |
| 8-K | 2024-10-02 | 2024-10-01 | |
| 10-K | 2024-09-30 | 2024-06-30 | |
| 8-K | 2024-07-16 | 2024-07-11 | |
| 6-K | 2024-06-03 | — | |
| 6-K | 2024-03-15 | — | |
| 20-F/A | 2024-01-17 | 2023-06-30 | |
| 6-K | 2024-01-04 | — | |
| 6-K | 2023-11-30 | — | |
| 6-K | 2023-11-28 | — | |
| 6-K | 2023-11-03 | — | |
| 20-F | 2023-10-18 | 2023-06-30 | |
| 6-K | 2023-10-16 | — | |
| 6-K | 2023-09-29 | — | |
| 6-K | 2023-09-28 | — | |
| 6-K | 2023-07-31 | — | |
| 6-K | 2023-07-28 | — | |
| 6-K | 2023-07-25 | — | |
| 6-K | 2023-07-24 | — | |
| 6-K | 2023-07-07 | — | |
| 6-K | 2023-07-07 | 2023-04-28 | |
| 6-K | 2023-07-03 | — | |
| 6-K | 2023-04-27 | — | |
| 6-K | 2023-03-09 | — | |
| 6-K | 2023-02-23 | — |
Showing 1–50 of 80 filings
Key facts
CIK
1191070
CUSIP
64136E102
13F (30d)
20 filings
20 filers
Visit website
Investor relations